Sentences with phrase «human embryonic stem cell research»

It would accommodate evolving and expanding areas of stem cell study, serving as a university and regional hub for human embryonic stem cell research.

The morality of human embryonic stem cell research has long been contentious, but new discoveries could end the controversy.

However, some consider human embryonic stem cell research controversial because, in some cases, the new stem cell lines are derived frozen human embryos that have been donated for research.

The bill was put forth to loosen the restrictions Bush placed on human embryonic stem cell research on August 9, 2001, when he banned federal funding for work with any stem cell line created after that date.

Even Dr. James Thompson, the researcher credited with being the first to successfully derive human embryonic stem cells, has admitted: «If human embryonic stem cell research does not make you at least a bit uncomfortable, you have not thought about it enough.

University of Wisconsin scientist, James A. Thomson, who first derived ESCs from embryos, has said «if human embryonic stem cell research does not make you at least a little bit uncomfortable, you have not thought about it enough.»

Robert Klein, chairman of the CIRM bragged that the grants «make us the highest funder of human embryonic stem cell research in the world.»

Beginning in the 1990's, and throughout the first years of the 21st century, perhaps no other political or social cause célèbre attracted as many celebrities as human embryonic stem cell research (hESCR).

A new study confirms a seemingly obvious assumption about human embryonic stem cell research: Countries with fewer restrictions on research outperform countries with more restrictions.

February 2010 - Italian stem cell scientists challenge goverment EuroSyStem scientist Elena Cattaneo challenges Italian government - the story continues In the summer of 2009, three Italian stem celli scientists unsuccessfully challenged their government in the courts over its decision to exclude human embryonic stem cell research from a ministerial funding call for projects on stem cell biology.

That study found that since MSCRF first began awarding grants in 2007, its pattern of giving shifted over the years from strongly favoring projects focusing on ethically contentious human embryonic stem cell research (hESCR) to projects focusing on ethically non-contentious adult stem cells and other non-embryonic stem cell research.

ESCR scientists are mounting a furious political assault against the lawsuit, currently back in Royce Lamberth's court urging that human embryonic stem cell research continue to be funded by the Feds, hoping to pressure the judge to see it their way.

One of the best talks of this conference was given by Dr. Renee Reijo Pera, Professor and Director of the Center for Human Embryonic Stem Cell Research at Stanford University.

But though stem cell research in general is booming in Germany, the political implications of human embryonic stem cell research remain unresolved.

Lamberth, who ordered a temporary ban on federal funding for human embryonic stem cells research last August that an appeals court later overturned, is expected to issue a final ruling on the matter as soon as this summer.

The two researchers analyzed nationally representative surveys collected between 2002 and 2010 with the goal of better understanding how the U.S. public came to form opinions in the debate over human embryonic stem cell research.

But as this research into the origins and possible treatment of Down syndrome and other developments shows (e.g., here, here, and here), the non-embryonic «alternative» is fast outpacing the much - hyped human embryonic stem cell research in advancing the field of regenerative medicine.

I pray for the day when James A. Thomson and others in favor of human embryonic stem cell research think about it enough to be totally uncomfortable.

Proponents of destructive human embryonic stem cell research have all too often been quick to dismiss ethical concerns over the commodification and destruction of human life, concerns, they say, that represent an obstacle to the pursuit of science.

In 2014, Minnesota became the most recent of a handful of states that provide state funding for all types of stem cell research, including human embryonic stem cell research.

Thomas Hungar, of the Washington law firm Gibson, Dunn, argued for the plaintiffs that «it is undisputed in this case that human embryonic stem cell research always entails the destruction of embryos.»

The attempt by two adult stem cell researchers to quash US funding for human embryonic stem cell research reached a critical juncture this morning, as a high - profile appeals court heard key oral arguments in the case.

The vote will have little direct impact on human embryonic stem cell research, but the potential threat to reproductive technology and abortion rights is more immediate

Without these two technologies that you'll hear about in a moment, there would be no such thing as human embryonic stem cell research, and President Bush could have enjoyed his summer vacation in Crawford without having to agonize over the baptism of the infamous 64 stem cell lines.

But for well over a decade now, ethically contentious human embryonic stem cell research (hESCR) has notably failed to live up to all its hype, with promises of miracle cures within «five to 10 years» remaining unfulfilled.

Wicker, no political naïf, brought out the big rhetorical ammo, reminding the senators that it was Jamie Thomson, the University of Wisconsin scientist who first reported isolating the cells in 1998, who said: «If human embryonic stem cell research does not make you at least a bit uncomfortable, you have not thought about it enough.»

Frequently lost in the policy discussions about human embryonic stem cells research are concrete realities that will determine how quickly such research will result in treatments and cures.

Daley, the associate director of the stem cell programme at Children's Hospital Boston, decried his opponents» portrayal of human embryonic stem cell research as replaceable with adult stem cell research or work on induced pluripotent cells.

As issues at the interface of science and society — from disease research to global climate change, evolution, human embryonic stem cell research, neuroscience, and others — take on increasing importance, the Early Career Award for Public Engagement with Science seeks to encourage efforts to promote interactive dialogue between scientists and non-scientific, public audiences.

As issues at the interface of science and society — from disease research to global climate change, evolution, human embryonic stem cell research, neuroscience, and others — take on increasing importance, the new Early Career Award for Public Engagement with Science seeks to encourage efforts to promote interactive dialogue between scientists and non-scientific, public audiences.

In the months before Framework 6 was adopted, a coalition of countries threatened to block the entire program over funding for human embryonic stem cell research, which is restricted or even forbidden in some E.U. countries.

«I think this is the best option we have ever had,» says Renee Reijo Pera, director of Stanford University's Center for Human Embryonic Stem Cell Research and Education in California, who wasn't involved in the study.

Last Thursday, a National Institutes of Health (NIH) advisory committee rejected a request to use 47 lines in federally funded human embryonic stem cell research, saying that the donors had given away too many rights.

A Washington, D.C., judge said this afternoon that his ruling 2 weeks ago, halting all federal funding for human embryonic stem cell research, will stand while the case moves forward.

Israel is another hotspot for stem cell research, and according to Trounson, is second only to the United States in terms of its research paper output on human embryonic stem cell research.

In 2004 Blackburn and ethicist William F. May made headlines when the Bush administration ousted them from the President's Council on Bioethics for their strong public support of human embryonic stem cell research.

This barrier has been highly visible in the field of human embryonic stem cell research, where researchers in the United States must adhere to legislation and funding limitations that researchers in European countries have not faced.

«It would be a big mistake,» Meissner notes, «to say, «now we can generate these [reprogrammed] cells, [so] we have to stop all human embryonic stem cell research.»»

«We are in an era where the primary issues are not federal funding for human embryonic stem cell research,» wrote CAMR President Amy Comstock Rick, who is also CEO of the Parkinson's Action Network, in an e-mail to the more than 100 patient advocacy, scientific, and other groups that belong to CAMR.

So as President Bush nears the end of his term, the future of human embryonic stem cell research is as uncertain than ever.

Among scientists, she may be best known as the defendant on Sherley v. Sebelius, a lawsuit challenging federal funding for human embryonic stem cell research that the government ultimately won.

U.S. Supreme Court rejects petition calling for ban on taxpayer - funded human embryonic stem cell research

«We saw better germ - cell differentiation in this transplantation model than we've ever seen,» said Renee Reijo Pera, PhD, former director of Stanford's Center for Human Embryonic Stem Cell Research and Education.

In The Language of God, Collins included an appendix in which he explicitly dealt with the morality of human embryonic stem cell research.

Just prior to the announcement about Collins, the NIH published its final guidelines for the use of federal funds in human embryonic stem cell research.

It would seem that the California Institute for Regenerative Medicine (CIRM) is not alone as it increasingly moves away from human embryonic stem cell research (hESCR) and towards adult and other non-embryonic avenues of stem cell research.

Two recent developments involving the California Institute for Regenerative Medicine (CIRM) again serve to underscore the reality that adult and other non-embryonic avenues of stem cell research are advancing at a far more dramatic pace toward providing actual therapeutic benefits for patients than is human embryonic stem cell research (hESCR).

The birthday greeting contained an unintended irony, for while CIRM was approved by California voters a decade ago to give priority funding to human embryonic stem cell research, eight of the 10 approved clinical trials referenced by City of Hope were for research projects using adult and other non-embryonic stem cells.